Randomized phase II clinical trial comparing tremelimumab (CP-675,206) with best supportive care (BSC) following first-line platinum-based therapy in patients (pts) with advanced non small cell tung cancer ( NSCLC )

查看全文 作　　者：ZATLOUKAL P; HEO DS; PARK K; 出　　处：《J Clln Oncol》索引2009年第27卷第15期,共0页